ACHILLION PHARMACEUTICALS INC Insider Trading for June 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACHILLION PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACHILLION PHARMACEUTICALS INC for June 2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 24 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 8.30 | 80,000 | 663,600 | 22,486,007 | 22.6 M to 22.5 M (-0.35 %) |
Jun 24 2014 | ACHN | ACHILLION PHARMACE ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Sell | S | 8.41 | 800,000 | 6,726,800 | 22,566,007 | 23.4 M to 22.6 M (-3.42 %) |
Jun 18 2014 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Sell | S | 7.79 | 224,400 | 1,748,076 | 8,868,753 | 9.1 M to 8.9 M (-2.47 %) |
Jun 18 2014 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Sell | S | 7.71 | 944,400 | 7,281,324 | 9,093,153 | 10 M to 9.1 M (-9.41 %) |
Jun 18 2014 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Sell | S | 7.81 | 150,000 | 1,171,500 | 10,037,553 | 10.2 M to 10 M (-1.47 %) |
Jun 18 2014 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Sell | S | 7.85 | 100,000 | 785,000 | 10,187,553 | 10.3 M to 10.2 M (-0.97 %) |
Jun 18 2014 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Sell | S | 7.57 | 400,751 | 3,033,685 | 10,287,553 | 10.7 M to 10.3 M (-3.75 %) |
Jun 17 2014 | ACHN | ACHILLION PHARMACE ... | FRASHIER GARY E | Director | Option Exercise | M | 3.10 | 35,000 | 108,500 | 15,000 | |
Jun 17 2014 | ACHN | ACHILLION PHARMACE ... | FRASHIER GARY E | Director | Option Exercise | M | 3.28 | 16,250 | 53,300 | 3,750 | |
Jun 17 2014 | ACHN | ACHILLION PHARMACE ... | FRASHIER GARY E | Director | Option Exercise | M | 1.05 | 3,750 | 3,938 | 0 | |
Jun 17 2014 | ACHN | ACHILLION PHARMACE ... | FRASHIER GARY E | Director | Sell | S | 8.00 | 35,000 | 280,000 | 0 | 35 K to 0 (-100.00 %) |
Jun 17 2014 | ACHN | ACHILLION PHARMACE ... | FRASHIER GARY E | Director | Buy | M | 3.10 | 35,000 | 108,500 | 35,000 | 0 to 35 K |
Jun 17 2014 | ACHN | ACHILLION PHARMACE ... | FRASHIER GARY E | Director | Sell | S | 8.00 | 16,250 | 130,000 | 0 | 16.3 K to 0 (-100.00 %) |
Jun 17 2014 | ACHN | ACHILLION PHARMACE ... | FRASHIER GARY E | Director | Buy | M | 3.28 | 16,250 | 53,300 | 16,250 | 0 to 16.3 K |
Jun 17 2014 | ACHN | ACHILLION PHARMACE ... | FRASHIER GARY E | Director | Sell | S | 8.00 | 3,750 | 30,000 | 0 | 3.8 K to 0 (-100.00 %) |
Jun 17 2014 | ACHN | ACHILLION PHARMACE ... | FRASHIER GARY E | Director | Buy | M | 1.05 | 3,750 | 3,938 | 3,750 | 0 to 3.8 K |
Jun 17 2014 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | EVP, Chief Commerci ... | Option Exercise | M | 0.82 | 25,000 | 20,500 | 25,000 | |
Jun 17 2014 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | EVP, Chief Commerci ... | Sell | S | 7.82 | 25,000 | 195,500 | 0 | 25 K to 0 (-100.00 %) |
Jun 17 2014 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | EVP, Chief Commerci ... | Buy | M | 0.82 | 25,000 | 20,500 | 25,000 | 0 to 25 K |
Jun 12 2014 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Sell | S | 7.71 | 36,000 | 277,560 | 10,688,304 | 10.7 M to 10.7 M (-0.34 %) |
Jun 12 2014 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Sell | S | 7.57 | 51,024 | 386,252 | 10,724,304 | 10.8 M to 10.7 M (-0.47 %) |
Jun 12 2014 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Sell | S | 7.67 | 16,425 | 125,980 | 10,775,328 | 10.8 M to 10.8 M (-0.15 %) |
Jun 12 2014 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Sell | S | 7.78 | 25,200 | 196,056 | 10,791,753 | 10.8 M to 10.8 M (-0.23 %) |
Jun 11 2014 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | EVP, Chief Commerci ... | Option Exercise | M | 0.82 | 48,950 | 40,139 | 50,000 | |
Jun 11 2014 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | EVP, Chief Commerci ... | Option Exercise | M | 0.82 | 1,050 | 861 | 98,950 | |
Jun 11 2014 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | EVP, Chief Commerci ... | Sell | S | 6.05 | 48,950 | 296,148 | 0 | 49 K to 0 (-100.00 %) |
Jun 11 2014 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | EVP, Chief Commerci ... | Buy | M | 0.82 | 48,950 | 40,139 | 48,950 | 0 to 49 K |
Jun 11 2014 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | EVP, Chief Commerci ... | Sell | S | 4.82 | 1,050 | 5,061 | 0 | 1.1 K to 0 (-100.00 %) |
Jun 11 2014 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | EVP, Chief Commerci ... | Buy | M | 0.82 | 1,050 | 861 | 1,050 | 0 to 1.1 K |
Jun 11 2014 | ACHN | ACHILLION PHARMACE ... | KISHBAUCH MICHAEL D | Director | Option Exercise | M | 3.10 | 371,937 | 1,153,005 | 0 | |
Jun 11 2014 | ACHN | ACHILLION PHARMACE ... | KISHBAUCH MICHAEL D | Director | Sell | S | 7.75 | 371,937 | 2,882,512 | 0 | 371.9 K to 0 (-100.00 %) |
Jun 11 2014 | ACHN | ACHILLION PHARMACE ... | KISHBAUCH MICHAEL D | Director | Buy | M | 3.10 | 371,937 | 1,153,005 | 371,937 | 0 to 371.9 K |